TITLE

Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery

AUTHOR(S)
Karabulut, Hasan; Toraman, Fevzi; Evrenkaya, Serdar; Goksel, Onur; Tarcan, Sumer; Alhan, Cem
PUB. DATE
March 2004
SOURCE
European Journal of Cardio-Thoracic Surgery;Mar2004, Vol. 25 Issue 3, p419
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: Platelet dysfunction is one of the major reasons of postoperative bleeding following coronary artery surgery. The aim of this study was to evaluate the effects of clopidogrel; a specific and potent irreversible inhibitor of platelet aggregation; on bleeding and use of blood and blood products after coronary artery bypass surgery (CABG). Methods: Preoperative patient characteristics and perioperative and postoperative data were collected prospectively in 1628 consecutive patients undergoing isolated CABG performed by the same surgical and anesthesia team. Of these, 48 were receiving clopidogrel preoperatively. Of the 1628 patients, 1456 underwent elective and 172 (10.6%) underwent non-elective operation. Thirty-six (2.5%) of the elective patients and 12 (7%) of the non-elective patients were using clopidogrel, preoperatively. Baseline characteristics, chest tube output, and the need for reexploration or for blood and blood product transfusion of clopidogrel recipients and non-recipients were compared. The clopidogrel group had higher prothrombin time level (12.6±1.6; 11.5±1.7 s, P=0.013), however comparable aPTT level (32.6±4.5 vs. 31.4±4.5 s), and platelet count (275 000±98 000 vs. 280 000±72 000 dl−1). Results: The need for reexploration or for blood and blood product transfusion, chest tube output, ICU length of stay (20.1±2.9 vs. 21.9±13.5 h; P=NS), and hospital length of stay (5.5±1.7 vs. 5.4±2.1 days; P=NS) were similar in clopidogrel recipients and non-recipients, respectively. Further analysis demonstrated no significant difference in use of homologous blood or fresh frozen plasma, amount of postoperative bleeding and reoperation rates for bleeding as well as length of intensive care unit and hospital stay between the clopidogrel and the control groups both in elective and non-elective patients. Conclusions: The results of this study suggest that preoperative use of clopidogrel is not associated with increased bleeding and need for surgical exploration as well as risk of blood and blood product transfusion after CABG.
ACCESSION #
12436035

 

Related Articles

  • Initial Experience with Beating Heart Surgery: Comparison with Fast-Track Methods. Ott, Richard A.; Gutfinger, Dan E. // American Surgeon;Nov1999, Vol. 65 Issue 11, p1018 

    Cardiopulmonary bypass (CPB) in coronary artery bypass grafting (CABG) may increase postoperative complications in high-risk patients. The goal of this study is to retrospectively review a series of consecutive patients undergoing conventional CABG using a fast-track recovery method and to...

  • New Coronary Artery Bypass Options.  // USA Today Magazine;Oct2001, Vol. 130 Issue 2677, p4 

    Focuses on the popularity of the use of off-pump heart surgery in coronary artery bypass operations. Advantages of the technique.

  • Coronary artery bypass graft with biventricular microaxial pumps. Meyns, B.; Sergeant, P. // Perfusion;1999, Vol. 14 Issue 4, p288 

    Investigates the use of biventricular microaxial pumps for coronary artery bypass graft procedure. Information on the mechanical support system; Intended clinical use of the device.

  • Editorial To risk or not to risk. Punjabi, Prakash P. // Perfusion;Sep2008, Vol. 23 Issue 5, p253 

    The article discusses various reports published within the issue including one on the use of decision analysis and meta analysis in predicting outcomes in coronary artery bypass grafting surgery, and another one about ECHO parameters of diastolic dysfunction and the effect of clenbuterol...

  • Angioplasty safe without cardiac surgery backup.  // OR Manager;Jan2012, Vol. 28 Issue 1, p23 

    The article reports that percutaneous coronary interventions (PCIs) performed at hospital without surgical backup, do not increase the in-hospital mortality or the requirement of the emergency coronary bypass surgery in the U.S.

  • CARDIAC BYPASS without the pump. Munro, Nancy // RN;Oct2003, Vol. 66 Issue 10, p28 

    Focuses on off-pump coronary artery bypass. Surgery for coronary artery disease patients; Risk and advantages of the machine; Inflammatory response; Assessment for postop complications; Other organs affected. INSET: Systemic inflammatory response syndrome..

  • Heart of the matter. Milton, Philip // Money Marketing;1/21/2010, p40 

    In this article the author reflects on his triple heart bypass surgery relative to those people who decided to sell their businesses and give up their jobs.

  • Is coronary bypass surgery really safe? CHUA, PHILIP S. // Filipino Reporter;6/6/2014, Vol. 42 Issue 27, p35 

    The article presents questions and answers related to coronary bypass surgery including whether heart bypass is an open heart surgery or not, whether the heart has to be stopped during surgery or not, and the concept of Robotic heart surgery.

  • Author's Reply. Caluk, Selma; Caluk, Jasmin // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Jan2016, Vol. 16 Issue 1, p69 

    A response from the author of the article "Osmanovic E. Nonthyroidal illness syndrome in off-pump coronary artery bypass surgery," in the 2015 issue is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics